Journal of Cancer Research

Welcome to the Journal of Cancer Research (JCR), an international, peer-reviewed, open-access journal dedicated to advancing knowledge in the field of oncology. Our mission is to provide a trusted platform for the dissemination of high-quality research that addresses the complex challenges of cancer biology, prevention, diagnosis, and treatment.

Cancer remains one of the leading health concerns worldwide, and scientific breakthroughs are transforming how we understand and manage this disease. The Journal of Cancer Research seeks to bridge the gap between laboratory discoveries, clinical practice, and public health by publishing cutting-edge research and fostering collaboration across disciplines.

✦ What We Publish

The journal welcomes original research articles, comprehensive reviews, clinical studies, case reports, short communications, and commentaries in all areas of cancer science, including but not limited to:

• Molecular and cellular oncology
• Cancer genetics and epigenetics
• Tumor immunology and immunotherapy
• Precision medicine and targeted therapies
• Early detection, biomarkers, and diagnostics
• Clinical trials and translational research
• Radiation and surgical oncology
• Cancer prevention, epidemiology, and survivorship

✦ Our Commitment

At JCR, we are committed to:

• Upholding the highest standards of scientific integrity and ethical publishing.
• Ensuring rigorous peer review by experts in oncology and related fields.
• Providing rapid, fair, and constructive feedback to authors.
• Promoting open access to research, enabling global visibility and impact.

✦ Why Publish with Us?

• Wide Reach: Global visibility through SCICONX Publishing’s open-access platform.
• Interdisciplinary Impact: Encouraging collaboration among basic scientists, clinicians, and public health researchers.
• Timely Publication: Efficient editorial and review processes to accelerate the sharing of knowledge.
• Author Support: Clear submission guidelines, responsive editorial assistance, and transparent processes.

✦ Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of € 99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.

We invite researchers, clinicians, and scholars to contribute their work and be part of a growing community dedicated to improving cancer outcomes worldwide.

Join us in advancing the future of cancer research.